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Introduction
Pneumonic pasteurellosis is the most
common respiratory disease of sheep
and goats throughout the world, in-
cluding Malaysia. It has been known to
develop following stressful condition,
and vaccination has been used to con-
trol the disease. However, the detailed
pathogenesis and disease development
has not been studied while the avail-
able vaccines are ineffective. Thus, the
objectives of this study were:
To understand the detailed develop-
ment of this disease;
To determine the protective role of
local immunity in the respiratory tract
against the development of the disease
to identify the most suitable antigenic
component to be used in vaccine prepa-
ration against the disease.
Materials and Methods
a. Disease development: Goats infected
with P. haemolyica A2 were serially
slaughtered before the lungs were ex-
amined under electron microscope to
determine the time taken to establish
the infection. Smears were prepared
from the lung lavage fluid, stained with
Giemsa and examined under micro-
scope to identify and determine the
number of phagocytosis by the alveolar
macrophages.
b. Local Immunity: P. haemolytica A2
was introduced intranasally into goats.
After 2 weeks, they were slaughtered.
Lungs were lavaged before the right
apical lobe was fixed in formalin for
histological examination. The left api-
cal lobes were maintained in laboratory
(explant). The lung explants were then
challenged with live P. haemolytica
before they were examined under SEM
to determine the level of bacterial at-
tachment. Lung lavage fluid was sub-
jected to ELISA to determine the IgA
and IgG levels. At the end of the ex-
periment, the goats were challenged
with live P. haemolytica to determine
the disease establishment.
c.Antigenic Component: The outer
membrane proteins (OMP) were ex-
tracted from P. haemolytica. They were
electrophoresed before Western blot-
ting was carried out to determine the
most antigenic portion. The OMP was
then prepared as a crude vaccine and
injected into goats before the goats
were challenged with live P. haemo-
lytica. The extent of lung lesions was
compared.
Results and Discussion
Disease Development: The critical time
for the establishment of P. haemolytica
A2 infection is between 4-7 days post-
infection. Those goats those were not
able to completely phagocytose the
bacteria within seven days showed
disease establishment.
Phagocytic activity by alveolar macro-
phages was significantly reduced fol-
lowing infection by P. haemolytica A2
compared to infection by Staph.
aureus. This was due to the ability of
P. haemolytica to produce leukotoxin
that reduced phagocytosis and en-
hanced infection.
Local immunity: P. haemolytica A2
either live or killed but introduced
intranasally at 2 weeks interval stimu-
lated the bronchus associated lymphoid
tissue (BALT) of the lung. This re-
sulted in reduced ability of bacteria
cells to attach to the stimulated lung
surface. Goats receiving intranasal
killed P. haemolytica showed increased
IgA and IgG levels in the lungs and
IgG level in the serum. Challenged
with live P. haemolytica A2 failed to
establish infection in the stimulated
goats.
Antigenic Component: The 30 kD
OMP of P. haemolytica A7 was found
to be most antigenic. Using the compo-
nent as vaccine, it was found to be the
most suitable candidate for sub-unit
pasteurella vaccine.
Conclusions
P. haemolytica A2 establishes infection
in the lung within 4-7 days post-
infection. Goats that fail to successfully
phagocytose all bacteria cells within 7
days will eventually develop the dis-
ease. Double intranasal administration
of killed P. haemolytica A2 stimulates
the local immunity, which protects
animals from infection. The 30 kD
outer membrane protein of P. haemo-
lytica A7 is most suitable for sub-unit
vaccine preparation against pneumonic
pasteurellosis.
Benefits from the study
The study gave a better understanding
of the disease development that bene-
fits the scientific community, under-
graduate students, and extension work-
ers in the Dept of Vet Services. Intra-
nasal Spray Vaccine benefits the farm-
ers, government farms and interna-
tional scientific community; and finally
antigenic identification of suitable
vaccine candidate will benefit post-
graduate students, and provide poten-
tial benefit to our farmers.
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